Dr Reddy's Laboratories Limited
| About us | Dr. Reddy's is now a research driven, value based, fully integrated pharmaceutical company. Dr. Reddy's competencies cover the entire pharmaceutical chain-basic research, finished dosages, generics, bulk actives, biotechnology and diagnostics. Dr reddy's has a leading presence in india and the world market for value-added branded finished dosages. Our generic formulations have also become very popular in quality-conscious regulated markets such as the us, europe and japan. Dr. Reddy's is the first asia pacific pharmaceutical company, outside japan, to be listed on the new york stock exchange. Dr. Reddy's high-tech facilities follow cgmp guidelines in the production of finished dosages. The manufacturing facilities are inspected and approved by regulatory bodies like the usfda, uk mca, south africa mcc. Dr reddy's facilities have also been acknowledged by: Canada-tpp, australia-tga. The facilities are approved for exports into the us, EU, canada, south africa, australia and new zealand. Dr. Reddy's manufactures about 100 bulk actives and several key intermediates in six bulk actives manufacturing facilities, which are cgmp approved& usfda inspected. Our facilities are approved by the usfda and other reputed international inspection agencies for all our major products. |
|---|---|
| Business Type | Buying Office |
| Products/Services | Pharmaceutical raw materials |
